Question

Difficulty: MediumRheumatology and Immunology

During a routine clinic visit, a 7171-year-old woman describes a 66-week history of profound stiffness in her shoulders, neck, and pelvic girdle. She reports that the stiffness is most severe upon awakening and typically lasts for 22 to 33 hours before gradually improving throughout the day. Over the past month, she has also experienced generalized fatigue and a 22-kg (4.44.4-lb) weight loss. She explicitly denies headaches, visual changes, scalp tenderness, and jaw pain with chewing. Her past medical history is notable for mild essential hypertension. Vital signs are within normal limits.

Physical examination reveals a well-appearing but visibly uncomfortable woman. There is no focal joint effusion, erythema, or warmth. Active range of motion in the shoulders and hips is limited by pain, but passive range of motion is fully preserved. Muscle strength is 5/55/5 in the proximal and distal extremities.

Laboratory studies show:

TestResultReference Range
Hemoglobin10.810.8 g/dL12.012.0-15.515.5 g/dL
Leukocyte count7,5007,500/mm3^34,5004,500-11,00011,000/mm3^3
Erythrocyte sedimentation rate8888 mm/h00-2020 mm/h
Creatine kinase8585 U/L4040-150150 U/L
Thyroid-stimulating hormone (TSH)2.42.4 μ\muU/mL0.50.5-5.05.0 μ\muU/mL

Which of the following is the most appropriate next step in the management of this patient?

  1. A
    Perform a temporal artery biopsy
  2. B
    Administer intravenous ceftriaxone
  3. Initiate low-dose oral prednisone therapyAnswer
  4. D
    Initiate levothyroxine therapy
  5. E
    Initiate fluoxetine therapy

Answer

Initiate low-dose oral prednisone therapy
The correct answer is to initiate low-dose oral prednisone therapy. This patient presents with the classic clinical triad for polymyalgia rheumatica (PMR): age greater than 5050 years, bilateral aching and morning stiffness (lasting >1>1 hour) in the proximal joint girdles (shoulders, neck, hips), and an elevated erythrocyte sedimentation rate (ESR). Furthermore, her normal creatine kinase level distinguishes this condition from inflammatory myopathies like polymyositis, where muscle weakness (rather than just pain-limited movement) and elevated muscle enzymes are prominent. Because she lacks any cranial symptoms (such as new-onset headache, visual disturbances, or jaw claudication), there is no clinical suspicion for concurrent giant cell arteritis (GCA). The gold-standard treatment for isolated PMR is low-dose oral glucocorticoids (e.g., 1010 to 2020 mg of prednisone daily), which typically results in rapid, dramatic symptom relief within 2424 to 7272 hours.

Step-by-Step Solution

1
Analyze the patient's demographic and clinical presentation.
A woman over age 5050 presents with symmetric aching and prolonged morning stiffness (>1>1 hour) in the shoulders and pelvic girdle, alongside systemic symptoms like fatigue and weight loss.
These are the hallmark clinical features of polymyalgia rheumatica (PMR).
2
Evaluate for 'red flag' symptoms of related conditions.
The patient explicitly denies headache, visual changes, scalp tenderness, and jaw claudication.
This rules out concurrent giant cell arteritis (GCA), meaning the patient has isolated PMR.
3
Interpret the laboratory findings to rule out mimics.
The ESR is markedly elevated (8888 mm/h), confirming systemic inflammation. Creatine kinase and TSH are normal.
Normal CK rules out inflammatory myopathies (e.g., polymyositis), and normal TSH rules out hypothyroid myopathy.
4
Determine the standard pharmacological intervention.
Select low-dose oral prednisone (1010-2020 mg/day).
Isolated PMR is highly responsive to low-dose glucocorticoids, which serve as both a diagnostic aid and the primary treatment.

Key Concept

Diagnosis and management of isolated polymyalgia rheumatica (PMR)
Estimated Time:1m 15s
Rate this question